BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diehl TM, Abbott DE. Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer. Curr Treat Options Oncol 2021;22:82. [PMID: 34224023 DOI: 10.1007/s11864-021-00878-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Tsung A, Adam MO, Pawlik TM, Kim AC. Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis. Ann Surg Oncol 2023;30:335-44. [PMID: 36149611 DOI: 10.1245/s10434-022-12513-0] [Reference Citation Analysis]
2 Li Y, Chen Z, Han J, Ma X, Zheng X, Chen J. Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer. Front Oncol 2022;12:781233. [PMID: 35186730 DOI: 10.3389/fonc.2022.781233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chai S, Sun X, Fu C, Xu Q, Ren Z, Xie L, Ge J, Sang M. Identification and characterization of the inhibitory effect of ART on colorectal cancer cells using Raman spectroscopy. J Raman Spectroscopy. [DOI: 10.1002/jrs.6292] [Reference Citation Analysis]